Shanghai No. 1 Pharmaceutical Company Limited operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai No. 1 Pharmaceutical Company Limited with three other
drug stores in Asia:
Medical Ikkou Co Ltd
sales of 29.31 billion Japanese Yen [US$264.05 million]
of which 80%
Sapporo Clinical Laboratory Inc.
(17.53 billion Japanese Yen [US$157.93 million]
of which 63%
was Dispensing Pharmacy Business), and
Apex Healthcare Bhd
based in Malaysia
(581.27 million Malaysian Ringgits [US$146.34 million]
of which 94%
was Wholesale and Distribution).
During the year ended December of 2016, sales at
Shanghai No. 1 Pharmaceutical Company Limited were 1.52 billion Chinese Renmimbi (US$234.91 million).
a very small
increase of 1.9%
versus 2015, when the company's sales were 1.49 billion Chinese Renmimbi.
This was the third consecutive year of growth at Shanghai No. 1 Pharmaceutical Company Limited.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
9.8% in 2016, from
51.76 million Chinese Renmimbi to 56.85 million Chinese Renmimbi.
Shanghai No. 1 Pharmaceutical Company Limited also saw significant increases in sales in
Wholesale Trade (up 4.1% to 798.67 million Chinese Renmimbi)
Not all segments of Shanghai No. 1 Pharmaceutical Company Limited experienced an increase in sales in 2016:
sales of Pharmaceutical and Medicinal fell 1.3% to 663.51 million Chinese Renmimbi.